Patel Vyomesh, Hood Brian L, Molinolo Alfredo A, Lee Norman H, Conrads Thomas P, Braisted John C, Krizman David B, Veenstra Timothy D, Gutkind J Silvio
Oral and Pharyngeal Cancer Branch, National Institute of Craniofacial and Dental Research, NIH, Bethesda, Maryland 20892, USA.
Clin Cancer Res. 2008 Feb 15;14(4):1002-14. doi: 10.1158/1078-0432.CCR-07-1497.
Squamous cell carcinoma of the head and neck (HNSCC), the sixth most prevalent cancer among men worldwide, is associated with poor prognosis, which has improved only marginally over the past three decades. A proteomic analysis of HNSCC lesions may help identify novel molecular targets for the early detection, prevention, and treatment of HNSCC.
Laser capture microdissection was combined with recently developed techniques for protein extraction from formalin-fixed paraffin-embedded (FFPE) tissues and a novel proteomics platform. Approximately 20,000 cells procured from FFPE tissue sections of normal oral epithelium and well, moderately, and poorly differentiated HNSCC were processed for mass spectrometry and bioinformatic analysis.
A large number of proteins expressed in normal oral epithelium and HNSCC, including cytokeratins, intermediate filaments, differentiation markers, and proteins involved in stem cell maintenance, signal transduction, migration, cell cycle regulation, growth and angiogenesis, matrix degradation, and proteins with tumor suppressive and oncogenic potential, were readily detected. Of interest, the relative expression of many of these molecules followed a distinct pattern in normal squamous epithelia and well, moderately, and poorly differentiated HNSCC tumor tissues. Representative proteins were further validated using immunohistochemical studies in HNSCC tissue sections and tissue microarrays.
The ability to combine laser capture microdissection and in-depth proteomic analysis of FFPE tissues provided a wealth of information regarding the nature of the proteins expressed in normal squamous epithelium and during HNSCC progression, which may allow the development of novel biomarkers of diagnostic and prognostic value and the identification of novel targets for therapeutic intervention in HNSCC.
头颈部鳞状细胞癌(HNSCC)是全球男性中第六大最常见的癌症,其预后较差,在过去三十年中仅略有改善。对头颈部鳞状细胞癌病变进行蛋白质组学分析可能有助于识别用于早期检测、预防和治疗头颈部鳞状细胞癌的新分子靶点。
激光捕获显微切割技术与最近开发的从福尔马林固定石蜡包埋(FFPE)组织中提取蛋白质的技术以及一个新的蛋白质组学平台相结合。从正常口腔上皮以及高分化、中分化和低分化头颈部鳞状细胞癌的FFPE组织切片中获取约20,000个细胞,进行质谱分析和生物信息学分析。
在正常口腔上皮和头颈部鳞状细胞癌中表达的大量蛋白质,包括细胞角蛋白、中间丝、分化标志物以及参与干细胞维持、信号转导、迁移、细胞周期调控、生长和血管生成、基质降解的蛋白质,以及具有肿瘤抑制和致癌潜力的蛋白质,都很容易被检测到。有趣的是,许多这些分子的相对表达在正常鳞状上皮以及高分化、中分化和低分化头颈部鳞状细胞癌肿瘤组织中呈现出明显不同的模式。代表性蛋白质通过在头颈部鳞状细胞癌组织切片和组织微阵列中的免疫组织化学研究进一步得到验证。
将激光捕获显微切割技术与FFPE组织的深入蛋白质组学分析相结合的能力,提供了大量有关正常鳞状上皮中表达的蛋白质性质以及头颈部鳞状细胞癌进展过程中蛋白质性质的信息,这可能有助于开发具有诊断和预后价值的新生物标志物,并识别头颈部鳞状细胞癌治疗干预的新靶点。